Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Praharshinie Rupasinghe

3PUBLICATIONS
16CO-AUTHORS
Medical infection agents (incl. prions)Medical microbiology not elsewhere classifiedMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 22, 2025
<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>.

Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders

|Mar 27, 2024
Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin.

Praharshinie Rupasinghe, Azka Ashraf, Nadia Barreda

|Feb 09, 2024
Refined understanding of the impact of the <i>Mycobacterium tuberculosis</i> complex diversity on the intrinsic susceptibility to pretomanid.

Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken

Pageof 1

Frequent Collaborators

3 joint publications

Leen Rigouts

2 joint publications

Claudio U Köser

1 joint publications

Roger Calderon

1 joint publications

Elisa Ardizzoni

1 joint publications

Nabila Ismail

1 joint publications

Wim Mulders

1 joint publications

Robin M Warren

1 joint publications

Lavania Joseph

1 joint publications

Dumisani Ngcamu

1 joint publications

Thabisile Gwala

Frequent Collaborators

3 joint publications

Leen Rigouts

2 joint publications

Claudio U Köser

1 joint publications

Roger Calderon

1 joint publications

Elisa Ardizzoni

Top Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

Published on : Apr 05, 2017

9.0K
Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
07:28

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry

Published on : Oct 29, 2020

8.7K
Analysis of <sup>18</sup>FDG PET/CT Imaging as a Tool for Studying <em>Mycobacterium tuberculosis</em> Infection and Treatment in Non-human Primates
10:04

Analysis of <sup>18</sup>FDG PET/CT Imaging as a Tool for Studying <em>Mycobacterium tuberculosis</em> Infection and Treatment in Non-human Primates

Published on : Sep 05, 2017

18.8K
See more related videos

Top Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

Published on : Apr 05, 2017

9.0K
Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
07:28

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry

Published on : Oct 29, 2020

8.7K
Analysis of <sup>18</sup>FDG PET/CT Imaging as a Tool for Studying <em>Mycobacterium tuberculosis</em> Infection and Treatment in Non-human Primates
10:04

Analysis of <sup>18</sup>FDG PET/CT Imaging as a Tool for Studying <em>Mycobacterium tuberculosis</em> Infection and Treatment in Non-human Primates

Published on : Sep 05, 2017

18.8K
See more related videos